Pathstone Holdings Portfolio holdings
Pathstone Holdings is the parent company of Pathstone, a privately held wealth management firm for high net worth families and institutions. Matthew Fleissig, Steve Braverman and Allan Zachariah started Pathstone in 2010 as a multi-family office owned by its partners, and Fleissig is its chief executive. Pathstone offered tax, accounting and property management as an independent firm, not part of a bank or brokerage, and it picks outside investment managers rather than selling its own products. Pathstone bought Advisor Partners, a firm that builds portfolios from an index's individual stocks, in 2022, and that business became Concentric Innovation in 2025. It also acquired Veritable LP, among the oldest multi-family offices in the US, in 2023, and merged with the wealth advisory firm Hall Capital in 2024.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVR
NVR
|
+$204M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$165M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$150M |
| 4 |
SPDR Gold Trust
GLD
|
+$141M |
| 5 |
Silicon Laboratories
SLAB
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Russell 1000 Growth ETF
VONG
|
+$117M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$54.1M |
| 3 |
Vanguard Russell 2000 Growth ETF
VTWG
|
+$46.7M |
| 4 |
Baillie Gifford International Concentrated Growth ETF
BGCG
|
+$35.2M |
| 5 |
Keurig Dr Pepper
KDP
|
+$30.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 57.28% |
| 2 | Technology | 15% |
| 3 | Financials | 6.62% |
| 4 | Healthcare | 3.95% |
| 5 | Consumer Discretionary | 3.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
Bristol-Myers Squibb
BMY
$130B
| $16M | 0.04% |
256,107
-4,445
| -2% | -$281K |
2023 Q4
11 quarters
|
|
277
Ecolab
ECL
$86.7B
| $16M | 0.04% |
58,097
-863
| -1% | -$240K |
2023 Q4
11 quarters
|
|
278
Stryker
SYK
$118B
| $15.8M | 0.04% |
57,779
+6,244
| +12% | +$1.97M |
2023 Q4
11 quarters
|
|
279
Cambria Global EW 2 ETF
GEQ
$207M
| $15.8M | 0.04% |
+311,081
| New | +$16M |
2026 Q3
0 quarters
|
|
280
Blackstone
BX
$95B
| $15.7M | 0.04% |
137,365
+6,826
| +5% | +$893K |
2023 Q4
11 quarters
|
|
281
SRH Total Return Fund
STEW
$1.83B
| $15.6M | 0.04% |
898,418
+6,512
| +0.7% | +$119K |
2023 Q4
11 quarters
|
|
282
Accenture
ACN
$148B
| $15.5M | 0.04% |
84,553
+19,698
| +30% | +$3.33M |
2023 Q4
11 quarters
|
|
283
iShares US Technology ETF
IYW
$23.2B
| $15.5M | 0.04% |
58,515
-163
| -0.3% | -$40.7K |
2023 Q4
11 quarters
|
|
284
Canadian Pacific Kansas City
CP
$81.9B
| $15.5M | 0.04% |
182,247
+6,813
| +4% | +$618K |
2023 Q4
11 quarters
|
|
285
US Bancorp
USB
$95B
| $15.4M | 0.04% |
267,294
-855
| -0.3% | -$53.4K |
2023 Q4
11 quarters
|
|
286
Monolithic Power Systems
MPWR
$67.8B
| $15.3M | 0.04% |
11,378
+446
| +4% | +$584K |
2023 Q4
11 quarters
|
|
287
Elevance Health
ELV
$92.8B
| $15.3M | 0.04% |
39,904
+891
| +2% | +$356K |
2023 Q4
11 quarters
|
|
288
Intercontinental Exchange
ICE
$100B
| $15.3M | 0.04% |
101,328
+8,852
| +10% | +$1.34M |
2023 Q4
11 quarters
|
|
289
iShares Select Dividend ETF
DVY
$23.8B
| $15.2M | 0.04% |
100,173
+13,387
| +15% | +$2.16M |
2023 Q4
11 quarters
|
|
290
Medtronic
MDT
$132B
| $15.2M | 0.04% |
176,117
+24,564
| +16% | +$2.16M |
2023 Q4
11 quarters
|
|
291
BNY Mellon Strategic Municipal Bond Fund
DSM
$272M
| $15.2M | 0.04% |
2,915,333
-96,240
| -3% | -$556K |
2023 Q4
11 quarters
|
|
292
Lockheed Martin
LMT
$138B
| $15.2M | 0.04% |
37,785
+9,285
| +33% | +$5.1M |
2023 Q4
11 quarters
|
|
293
Sumitomo Mitsui Financial Group, Inc American Depositary Shares (each representing 1.2 shares of Common Stock)
SMFG
$156B
| $15.1M | 0.04% |
584,109
-12,983
| -2% | -$336K |
2023 Q4
11 quarters
|
|
294
State Street SPDR S&P Biotech ETF
XBI
$10.2B
| $15.1M | 0.04% |
37,371
+25,688
| +220% | +$4.06M |
2023 Q4
11 quarters
|
|
295
Illinois Tool Works
ITW
$81.7B
| $15.1M | 0.04% |
58,209
+5,989
| +11% | +$1.66M |
2023 Q4
11 quarters
|
|
296
Dimensional International Value ETF
DFIV
$22.5B
| $15.1M | 0.04% |
269,633
+3,756
| +1% | +$214K |
2023 Q4
11 quarters
|
|
297
Target
TGT
$73.3B
| $15M | 0.04% |
95,695
+6,709
| +8% | +$1.01M |
2023 Q4
11 quarters
|
|
298
Prologis
PLD
$122B
| $15M | 0.04% |
113,373
+3,921
| +4% | +$550K |
2023 Q4
11 quarters
|
|
299
American Tower
AMT
$88.9B
| $14.9M | 0.04% |
90,790
+466
| +0.5% | +$80K |
2023 Q4
11 quarters
|
|
300
Altria Group
MO
$131B
| $14.8M | 0.04% |
219,947
+2,324
| +1% | +$161K |
2023 Q4
11 quarters
|
|
Similar funds
Pathstone Holdings's Q3 2026 Portfolio in Review
As of Q3 2026, Pathstone Holdings held 2,499 positions worth $36.2B, up 5.5% from $34.3B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Pathstone Holdings deployed $2.69B of net new capital in Q3 2026, opening 168 new positions and adding to 1,300 existing holdings. Its largest new stake was JPMorgan Active Growth ETF: 809,296 shares worth $38.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, up from 57% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard Russell 1000 Growth ETF, an estimated $117M trimmed.
- Pathstone Holdings's largest Q3 2026 buy was JPMorgan Active Growth ETF: 809,296 shares worth $38.3M.
- Pathstone Holdings added most to NVR in Q3 2026, an estimated $204M increase.
- Pathstone Holdings's biggest Q3 2026 reduction was Vanguard Russell 1000 Growth ETF, cutting an estimated $117M.
- Pathstone Holdings fully exited abrdn National Municipal Income Fund in Q3 2026, selling an estimated $7.53M.
- Pathstone Holdings's ten largest holdings make up 31% of its $36.2B portfolio in Q3 2026.
- Pathstone Holdings opened 168 new positions and closed 110 in Q3 2026.
- Pathstone Holdings's portfolio value rose 5.5% quarter-over-quarter to $36.2B.
Based on Pathstone Holdings's 13F filing for Q3 2026, filed 13 Nov 2026.